UPK3A+ umbrella cell damage mediated by TLR3-NR2F6 triggers programmed destruction of urothelium in Hunner-type interstitial cystitis/painful bladder syndrome
- PMID: 38551071
- DOI: 10.1002/path.6275
UPK3A+ umbrella cell damage mediated by TLR3-NR2F6 triggers programmed destruction of urothelium in Hunner-type interstitial cystitis/painful bladder syndrome
Abstract
Urothelial damage and barrier dysfunction emerge as the foremost mechanisms in Hunner-type interstitial cystitis/bladder pain syndrome (HIC). Although treatments aimed at urothelial regeneration and repair have been employed, their therapeutic effectiveness remains limited due to the inadequate understanding of specific cell types involved in damage and the lack of specific molecular targets within these mechanisms. Therefore, we harnessed single-cell RNA sequencing to elucidate the heterogeneity and developmental trajectory of urothelial cells within HIC bladders. Through reclustering, we identified eight distinct clusters of urothelial cells. There was a significant reduction in UPK3A+ umbrella cells and a simultaneous increase in progenitor-like pluripotent cells (PPCs) within the HIC bladder. Pseudotime analysis of the urothelial cells in the HIC bladder revealed that cells faced challenges in differentiating into UPK3A+ umbrella cells, while PPCs exhibited substantial proliferation to compensate for the loss of UPK3A+ umbrella cells. The urothelium in HIC remains unrepaired, despite the substantial proliferation of PPCs. Thus, we propose that inhibiting the pivotal signaling pathways responsible for the injury to UPK3A+ umbrella cells is paramount for restoring the urothelial barrier and alleviating lower urinary tract symptoms in HIC patients. Subsequently, we identified key molecular pathways (TLR3 and NR2F6) associated with the injury of UPK3A+ umbrella cells in HIC urothelium. Finally, we conducted in vitro and in vivo experiments to confirm the potential of the TLR3-NR2F6 axis as a promising therapeutic target for HIC. These findings hold the potential to inhibit urothelial injury, providing promising clues for early diagnosis and functional bladder self-repair strategies for HIC patients. © 2024 The Pathological Society of Great Britain and Ireland.
Keywords: Hunner‐type interstitial cystitis/bladder pain syndrome; NR2F6; TLR3; single‐cell RNA sequencing; urothelium.
© 2024 The Pathological Society of Great Britain and Ireland.
References
-
- Clemens JQ, Erickson DR, Varela NP, et al. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol 2022; 208: 34–42.
-
- Akiyama Y, Hanno P. Phenotyping of interstitial cystitis/bladder pain syndrome. Int J Urol 2019; 26: 17–19.
-
- Ko KJ, Lim J, Yu J, et al. The impact of Hunner lesion‐type interstitial cystitis/bladder pain syndrome on health‐related quality of life and the effects of transurethral ablation. Qual Life Res 2022; 31: 3221–3228.
-
- Lai HH, Pickersgill NA, Vetter JM. Hunner lesion phenotype in interstitial cystitis/bladder pain syndrome: a systematic review and meta‐analysis. J Urol 2020; 204: 518–523.
-
- Whitmore KE, Fall M, Sengiku A, et al. Hunner lesion versus non‐Hunner lesion interstitial cystitis/bladder pain syndrome. Int J Urol 2019; 26: 26–34.
Publication types
MeSH terms
Substances
Grants and funding
- GZC20231815/China Postdoctoral Researcher Sponsorship Program
- 2022NSFSC1308/Natural Science Foundation of Sichuan Province
- 24NSFSC7707/Natural Science Foundation of Sichuan Province
- 2021YFC2009100/National Key Research and Development Program of China
- 2021YFC2009102/National Key Research and Development Program of China
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases